Grant Support

Past

Research Advisory Committee, Department of Surgery, University of Michigan Medical Center: Enzyme Linked Immuno-spot assay (ELISPOT) analyzer.

$20,000 1999.

University of Michigan, Internal Support, Section of Pediatric Surgery;

07/01/96 - 06/30/97 ($30,000)
07/01/97 - 06/30/98 ($30,000)
07/01/98 - 06/30/99 ($30,000)

National Cancer Institute, R-29, CA 77471-01, Vaccine Therapy of Pediatric Malignancies Utilizing Dendritic Cells

Principle Investigator (50% effort)
Annual direct cost $70,000
Total cost $532,000
4/01/98-3/31/04

Current

ChildrenÕs Oncology Group #A NBL00P2, Perinatal Neuroblastoma: Expectant Observation Ð A ChildrenÕs Oncology Group Pilot Study

Co-Investigator
7/1/01-6/30/05

Children's Oncology Group #A RST03P1, A Pilot Phase II Study for Children with Infantile Fibrosarcoma

Co-Investigator
7/01/04-06-30-09

University of Michigan Medical School, Student Biomedical Research Program

1998-2002
$10,000

The Brian Morden Foundation

3/1/05-2/28/07
Funds given in support of submitted grant: Dendritic Cell Vaccine Therapy of Sarcoma Patients Post Stem Cell Transplantation
Principle Investigator (20% effort) $50,000

The Role of Virtual Reality Simulation in Integrated Operating Room Design

Co-Investigator (10% effort)
Total direct cost $ 117,601
(This grant is pending funding from the Stryker Corporation)

UM-Faculty Group Practice - Geiger (PI)

Clinical Research Initiatives Program-University of Michigan
3/1/05-2/28/07
Pilot study of dendritic cell vaccine therapy of solid tumor patients post stem cell transplant

Pilot study evaluating the ability of dendritic cell vaccines to generate anti-tumor specific T-cell responses in pediatric patients with solid tumors following antilogous hematopoetic stem cell transplant.